Siri Eldevik Håberg
Centre Director
Responsibilities
Siri Eldevik Håberg is the Director of the Centre for Fertility and Health, a Centre of Excellence (SFF) funded by the Research Council of Norway.
Håberg is a physician with main research interest in perinatal epidemiology. She has long experience with combining data from cohort studies, biological analyses and national registries.
Håberg's current research focus is on causes of fertility problems and fetal loss, and risk factors and consequences of assisted reproductive technologies. Her work involves registry based population studies, and studies of genetic and epigenetic associations with pregnancy exposures, pregnancy outcomes and early life diseases. Håberg has also been involved in several registry-based projects on influenza and Covid-19, safety of vaccinations and medications in pregnancy, during childhood and in the general population.
Håberg leads and collaborates in several international research groups on environmental exposures, pregnancy and child health outcomes. She is the Norwegian PI in the ERC Synergy project (BIOSFER) on fertility in young adults. See more at www.cefh.no
Projects and publications
- ADHD medication in pregnancy: understanding the population and outcomes related to treatment use and discontinuation
- Antioxidants and the development of leukemia in children
- ART - Assisted Conceptions - Pregnancy and childhood outcomes
- ART og kreft
- Best prediction of adverse pregnancy outcomes
- Betydningen av foreldres alder for barnets utvikling og mentale helse.
- Biomarkører for hjerte-kar lidelser under og etter svangerskap
- BIOSFER - Untangling biologic and social causes of low fertility in modern societies
- Centre for Fertility and Health
- COVID-19 og svangerskap (CoronaPreg)
- COVID19 infeksjon hos gravide i Norge
- Den maternelle effekten på barneastma
- Den norske influensastudien (NorFlu)
- DNA methylation in newborns compared to in utero exposures and health outcomes in children
- Epidemiological studies on benefits and harms of drug treatment – special focus on drug safety in pregnancy and childhood.
- ERC Starting Grant: INFERTILITY - Understanding the causal nature of the relationship between infertility and cardiovascular disease
- Folat, paracetamol og feber under svangerskapet og kognisjon hos barnet.
- Health Gap: Health, maturity, and gender gap in education
- Infeksjon, immunitet og ADHD
- InferCan: Uncovering the infertility-cancer connection.
- Interval between pregnancies, obstetric history and unwanted pregnancy outcomes
- Intrauterine environmental exposures and pregnancy outcomes
- Keisersnitt og infeksjoner hos barn
- Kvinners fruktbarhet og helse
- Menns risikofaktorer for uønsket svangerskapsutfall
- MoBa og Kreft
- Pardannelse blant unge voksne i Norge: et dyadisk perspektiv på verdier og barneønsker
- Prenatal eksponering for plast-kjemikalier og helse og utvikling hos barn og unge
- Psykofarmaka inkludert bruk av ADHD medisiner under graviditet - innsikt fra MoBa undersøkelsen
- RegFlu del 2: Nevrologiske sykdommer
- Risikofaktorer og helsekonsekvenser av reproduktiv helse gjennom livsløpet
- Sammenlikning av metoder for DNA metylering
- SCOPE – Scandinavian studies of Covid-19 in pregnancy
- Sickness in the family (SickFam) : A register study on the short- and long-term effects of severe sickness on family members
- Sikker COVID-19 vaksinering under svangerskapet
- Studie av assistert reproduktiv teknologi (START) - epigenetiske mekanismer
- Sykdomsbyrde analyser: prevalens, helseutgifter, helsetjenestebruk og komorbiditet
- Using MoBa to understand the Covid-19 pandemic
- Vaksinasjon de to første leveår, misdannelser, tidlig fødsel og vaksineeffekt
- YoungPsych: The interplay between social media and mental health in adolescents and young adults
- YoungWork: Young adults’ mental health and labor market exclusion – causes, consequences and trends